BioSpace News Archive

Drug Development

Pharmasset, Inc. Release: New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1

November 4, 2011
·
7 min read
Business

Inhibitex, Inc. Reports Third Quarter Financial Results and Recent Corporate Developments

November 4, 2011
·
1 min read
Business

GTx, Inc. Provides Corporate Update and Reports Third Quarter 2011 Financial Results

November 4, 2011
·
1 min read
Business

Sucampo Pharmaceuticals, Inc. Reports Third Quarter 2011 and Year to Date Financial Results

November 4, 2011
·
1 min read
Human Genome Sciences, Inc. to Report Successful Clinical Study Results of Its PICSO® System Designed to Improve Myocardial Perfusion Following Primary PCI

November 4, 2011
·
1 min read
Business

Celgene Corporation to Pump $45 Million into Quanticel to Discover Cancer Drugs, Gets Option to Acquire

November 4, 2011
·
5 min read
Business

Ablynx Regains Anti-TNF-Alpha Nanobody Rights from Pfizer Inc.

November 4, 2011
·
2 min read
Roche Pipeline Update to Endorse Recent Research Success

November 4, 2011
·
1 min read
Drug Development

Rexahn Pharmaceuticals, Inc.'s Serdaxin(R) Disappoints in Phase II Trial for Major Depressive Disorder

November 4, 2011
·
4 min read
Drug Development

Presidio Pharmaceuticals, Inc. Announces Clinical Proof-of-Concept Data for its First HCV NS5A Inhibitor, PPI-461, and Initiation of Clinical Testing for its Second-Generation NS5A Inhibitor, PPI-668

November 4, 2011
·
1 min read